LONDON – On Tuesday, Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) won their attempt to invalidate two […]
Pfizer and BioNTech Win Bid to Invalidate CureVac’s UK COVID Vaccine Patents Read More »
BERLIN – Losses at Germany’s BioNTech (NASDAQ: BNTX) quadrupled year-on-year in the second quarter, the company said on Monday, as
BioNTech (NASDAQ: BNTX) Q2 Losses Quadruple Amid Strategic Shift to Cancer Drugs Read More »
On Tuesday, BioNTech (NASDAQ: BNTX), the maker of the COVID-19 vaccine, said that its cancer drug candidate BNT111 significantly improved
BioNTech’s (NASDAQ: BNTX) Cancer Drug Meets Primary Endpoint in Phase 2 Trial Read More »
